Evidence map›Paper›PMID 38662967›Full record

ArticleACS synthetic biology2024

Diverse Combinatorial Biosynthesis Strategies for C-H Functionalization of Anthracyclinones.

Rongbin Wang, Benjamin Nji Wandi, Nora Schwartz, Jacob Hecht, Larissa Ponomareva, Kendall Paige, Alexis West, Kathryn Desanti, Jennifer Nguyen, Jarmo Niemi and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS synthetic biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Enhanced spinosad production inSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Rongbin WangDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.
Benjamin Nji WandiDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.ORCID 0000-0003-1071-3111
Nora SchwartzDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
Jacob HechtDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
Larissa Ponomareva
Kendall PaigeDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
Alexis WestDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
Kathryn DesantiDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
Jennifer NguyenDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.ORCID 0000-0002-4557-1638
Jarmo NiemiDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.ORCID 0000-0002-7447-8379
Jon S ThorsonORCID 0000-0002-7148-0721
Khaled A ShaabanORCID 0000-0001-7638-4942
Mikko Metsä-KeteläDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.ORCID 0000-0003-3176-2908
S Eric NyboDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.ORCID 0000-0001-7884-7787
Ferris State University · USUniversity of Turku · FIUniversity of Kentucky · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI M. Ashfaqul Alam · 2020 to 2026
$18.7M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
In Vitro Glycorandomization of Natural ProductsR37AI052218 · NIAID · UNIVERSITY OF KENTUCKY · PI THORSON, JON SCOTT · 2012 to 2021
$4.0M
Bruker AVANCE NEO 600 MHz High-Performance Digital NMR SpectrometerS10OD028690 · OD · UNIVERSITY OF KENTUCKY · PI GARNEAU-TSODIKOVA, SYLVIE · 2020 to 2020
$1.4M
Combinatorial biosynthesis and metabolism studies of novel tetracenomycinsR15CA252830 · NCI · FERRIS STATE UNIVERSITY · PI NYBO, ERIC · 2020 to 2020
$385k
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NCI NIH HHS R15 CA252830NIAID NIH HHS R37 AI052218NIGMS NIH HHS P20 GM130456NIH HHS S10 OD028690
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnthracyclinesPolyketide SynthasesStreptomyces coelicolorAnti-Bacterial AgentsBiosynthetic PathwaysHydroxylationStreptomycesAnthracyclinesAnti-Bacterial AgentsPolyketide SynthasesanthracyclinonesanticancerBioBricksnatural product biosynthesisoxygenaseStreptomyces coelicolorsynthetic biology

Identifiers

PMID38662967
PMCPMC11101304
OpenAlexW4395446086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.